US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alumis Inc.

4.59

+0.760019.84%

Post-market: 4.660.0700+1.53%19:08 EDT

Volume:906.67K

Turnover:4.08M

Market Cap:249.73M

PE:-0.44

High:4.84

Open:3.83

Low:3.82

Close:3.83

Loading ...

Overview Company News Filings

Acelyrin urges stockholders to vote for proposed merger with Alumis

Acelyrin Inc. Urges Stockholders to Vote for Value-Maximizing Merger with Alumis Ahead of Special Meeting

Press Release: ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis

Alumis Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Confident Outlook on Acelyrin-Alumis Merger Amid Shareholder Opposition

Alumis price target lowered to $14 from $15 at H.C. Wainwright

BRIEF-Alumis And Acelyrin Announce Amended Merger Agreement

Alumis Raises Share Consideration for Acelyrin Acquisition

MT Newswires Live

ACELYRIN, INC. Amends Merger Agreement with Alumis

Alumis Inc - Expects Runway to Fund Operations Into 2027

THOMSON REUTERS

Alumis and ACELYRIN Announce Amended Merger Agreement

THOMSON REUTERS

Alumis Inc - ACELYRIN Stockholders to Receive 0.4814 Shares of Alumis per Share

THOMSON REUTERS

Press Release: Alumis and ACELYRIN Announce Amended Merger Agreement

new option listings on April 9th

Alumis Down Over 31%, on Track for Record Percent Decrease -- Data Talk

Alumis Reaches US$465m Market Cap Benefiting Insider Stock Buying

Simply Wall St.

Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger

THOMSON REUTERS

Alumis Inc. Reports 2024 Results and Strategic Merger

Alumis Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Sector Update: Health Care Stocks Decline Tuesday Afternoon

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALMS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":4.59,"timestamp":1746216000000,"preClose":3.83,"halted":0,"volume":906667,"hourTrading":{"tag":"盘后","latestPrice":4.66,"preClose":4.59,"latestTime":"19:08 EDT","volume":2188,"amount":10078.44,"timestamp":1746227284078},"delay":0,"floatShares":4764683,"shares":54407327,"eps":-10.381567,"marketStatus":"Market Closed","change":0.76,"latestTime":"05-02 16:00:00 EDT","open":3.83,"high":4.84,"low":3.82,"amount":4081717.4579641996,"amplitude":0.266319,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.381567,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":3.83,"preHourTrading":{"tag":"盘前","latestPrice":3.83,"preClose":3.83,"latestTime":"09:29 EDT","volume":1526,"amount":5947.6588584,"timestamp":1746192599919},"postHourTrading":{"tag":"盘后","latestPrice":4.66,"preClose":4.59,"latestTime":"19:08 EDT","volume":2188,"amount":10078.44,"timestamp":1746227284078},"volumeRatio":4.221013752140059,"impliedVol":1.5263,"impliedVolPercentile":0.6471},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":4764683,"roa":"-87.31%","roe":"-198.66%","lyrEps":-10.381567,"volumeRatio":4.221013752140059,"shares":54407327,"dividePrice":0,"high":4.84,"amplitude":0.266319,"preClose":3.83,"low":3.82,"week52Low":3.18,"pbRate":"0.96","week52High":13.53,"institutionHeld":0,"latestPrice":4.59,"eps":-10.381567,"divideRate":0,"volume":906667,"delay":0,"ttmEps":-10.381567,"open":3.83,"prevYearClose":7.86,"prevWeekClose":4.28,"prevMonthClose":4.14,"prevQuarterClose":6.14,"fiveDayClose":4.28,"twentyDayClose":8.54,"sixtyDayClose":7.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532886742","title":"Acelyrin urges stockholders to vote for proposed merger with Alumis","url":"https://stock-news.laohu8.com/highlight/detail?id=2532886742","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532886742?lang=en_us&edition=fundamental","pubTime":"2025-05-02 01:45","pubTimestamp":1746121551,"startTime":"0","endTime":"0","summary":"ACELYRIN (SLRN) reiterated its confidence that the proposed combination with Alumis (ALMS) is the best path forward and the most value-maximizing o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acelyrin-urges-stockholders-to-vote-for-proposed-merger-with-alumis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acelyrin-urges-stockholders-to-vote-for-proposed-merger-with-alumis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4007","SLRN","BK4139"],"gpt_icon":0},{"id":"2532327886","title":"Acelyrin Inc. Urges Stockholders to Vote for Value-Maximizing Merger with Alumis Ahead of Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2532327886","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532327886?lang=en_us&edition=fundamental","pubTime":"2025-05-02 01:30","pubTimestamp":1746120616,"startTime":"0","endTime":"0","summary":"ACELYRIN, Inc. has announced its confidence in a proposed merger with Alumis Inc., scheduled for a stockholder vote on May 13, 2025. The merger aims to create a leading clinical-stage immunology company with a diversified portfolio of product candidates. ACELYRIN's Board of Directors emphasizes that the merger represents the culmination of a comprehensive and competitive process designed to maximize value for all stockholders. ACELYRIN stockholders are expected to retain approximately 48% ownership in the combined company, providing them with significant potential upside. The Board encourages stockholders to focus on the long-term benefits of the merger.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acelyrin Inc. published the origina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nNDL7fZyRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLRN","LU2210150020.SGD","BK4112","IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","BK4139","LU2095319765.USD","ALMS","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4007","BK4588","NDAQ"],"gpt_icon":0},{"id":"2532859188","title":"Press Release: ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis","url":"https://stock-news.laohu8.com/highlight/detail?id=2532859188","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532859188?lang=en_us&edition=fundamental","pubTime":"2025-05-02 01:30","pubTimestamp":1746120600,"startTime":"0","endTime":"0","summary":"Special Meeting of stockholders to vote on the transaction scheduled for May 13, 2025. Reminds stockholders to vote today FOR the proposed merger. LOS ANGELES, May 01, 2025  -- ACELYRIN, Inc. , a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today reiterated its confidence that the proposed combination with Alumis Inc.  is the best path forward and the most value-maximizing outcome for all ACELYRIN stockholders.Bruce Cozadd, Chair of the ACELYRIN Board of Directors and member of the independent transaction committee , said, \"The ACELYRIN Board and management team are confident that the proposed merger with Alumis represents the most value-maximizing path forward for our company's stockholders. The agreement with Alumis follows a comprehensive and competitive process facilitated by the ACELYRIN Board. Furthermore, it reflects successful efforts by our Board to negotiate a revised agreement with a mea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS","BK4139","SLRN"],"gpt_icon":0},{"id":"2531870530","title":"Alumis Price Target Maintained With a $14.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2531870530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531870530?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:46","pubTimestamp":1746009960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2025 06:46 ET (10:46 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2531082381","title":"Confident Outlook on Acelyrin-Alumis Merger Amid Shareholder Opposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2531082381","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531082381?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:16","pubTimestamp":1746008177,"startTime":"0","endTime":"0","summary":"In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price targ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/confident-outlook-on-acelyrin-alumis-merger-amid-shareholder-opposition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/confident-outlook-on-acelyrin-alumis-merger-amid-shareholder-opposition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2529373586","title":"Alumis price target lowered to $14 from $15 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2529373586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529373586?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:12","pubTimestamp":1745316772,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Alumis (ALMS) to $14 from $15 and keeps a Buy rating on the shares. The firm cites incremental d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-14-from-15-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-14-from-15-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"gpt_icon":0},{"id":"2529870756","title":"BRIEF-Alumis And Acelyrin Announce Amended Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529870756","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529870756?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:53","pubTimestamp":1745236410,"startTime":"0","endTime":"0","summary":"BRIEF-Alumis And Acelyrin Announce Amended Merger AgreementApril 21 (Reuters) - Alumis Inc ALMS.O:ALUMIS AND ACELYRIN ANNOUNCE AMENDED MERGER AGREEMENTALUMIS INC - ACELYRIN STOCKHOLDERS TO RECEIVE 0.4","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA46YLXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SLRN","ALMS"],"gpt_icon":0},{"id":"2529141872","title":"Alumis Raises Share Consideration for Acelyrin Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2529141872","media":"MT Newswires Live","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529141872?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:17","pubTimestamp":1745234276,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) and Acelyrin (SLRN) said Monday that they agreed on an amended merger deal that reflects an increased share consideration for each Acelyrin share.Under the amended agreement, Acelyrin sh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS","BK4139","SLRN","BK4007"],"gpt_icon":0},{"id":"2529874693","title":"ACELYRIN, INC. Amends Merger Agreement with Alumis","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874693","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529874693?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:57","pubTimestamp":1745233061,"startTime":"0","endTime":"0","summary":"ACELYRIN, INC. ( ($SLRN) ) just unveiled an announcement. On February 6, 2025, ACELYRIN, INC. entered into a merger agreement with Alumis Inc., whi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acelyrin-inc-amends-merger-agreement-with-alumis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acelyrin-inc-amends-merger-agreement-with-alumis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALMS","BK4007","INC","SLRN"],"gpt_icon":0},{"id":"2529879143","title":"Alumis Inc - Expects Runway to Fund Operations Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529879143?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:30","pubTimestamp":1745231400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA46YLXT:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007","SLRN","BK4139"],"gpt_icon":0},{"id":"2529879642","title":"Alumis and ACELYRIN Announce Amended Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879642","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529879642?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:30","pubTimestamp":1745231400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUAYZMWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALMS","SLRN","BK4007"],"gpt_icon":0},{"id":"2529687950","title":"Alumis Inc - ACELYRIN Stockholders to Receive 0.4814 Shares of Alumis per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2529687950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529687950?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:30","pubTimestamp":1745231400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUAYZMWC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ALMS","SLRN"],"gpt_icon":0},{"id":"2529879600","title":"Press Release: Alumis and ACELYRIN Announce Amended Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879600","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529879600?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:30","pubTimestamp":1745231400,"startTime":"0","endTime":"0","summary":"ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis. Merger maximizes the potential value for ACELYRIN stockholders and creates a stronger combined company, best-positioned to realize long-term value of multiple late-stage assets. Bruce Cozadd, Chair of the ACELYRIN Board of Directors and member of the Board Transaction Committee, said, \"Since announcing the merger, we have had extensive conversations with our stockholders who have expressed an understanding of the strategic rationale for this transaction, while also sharing their perspectives on the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2526636636","title":"new option listings on April 9th","url":"https://stock-news.laohu8.com/highlight/detail?id=2526636636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526636636?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:30","pubTimestamp":1744201816,"startTime":"0","endTime":"0","summary":"New option listings for April 9th include Alumis Inc (ALMS), LEVERAGE SHARES 2X LONG ASML DAILY ETF (ASMG), Arrivent Biopharma Inc (AVBP), REX BITC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/new-option-listings-on-april-9th?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/new-option-listings-on-april-9th?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","FDN","IE00BD6J9T35.USD","ALMS","BK4588","AVBP","LU0823434740.USD","LU0097036916.USD","BK4585","ASMG","LU0345774631.USD","BK4543","BK4147","LU1734074674.USD","LU0823434583.USD","LU2063271972.USD","LU0345774391.USD","03165","BK4139","IE0004445239.USD","BK4007"],"gpt_icon":0},{"id":"2526842476","title":"Alumis Down Over 31%, on Track for Record Percent Decrease -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2526842476","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526842476?lang=en_us&edition=fundamental","pubTime":"2025-04-09 03:22","pubTimestamp":1744140120,"startTime":"0","endTime":"0","summary":"Alumis Inc.  is currently at $6.93, down $3.14 or 31.18%. --Would be lowest close since March 31, 2025, when it closed at $6.14. --Down 47.89% from its all-time closing high of $13.30 on June 28, 2024. --Up 94.12% from its 52-week closing low of $3.57 on March 20, 2025. --Down 33.57% at today's intraday low; largest intraday percent decrease on record ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2525710867","title":"Alumis Reaches US$465m Market Cap Benefiting Insider Stock Buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2525710867","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525710867?lang=en_us&edition=fundamental","pubTime":"2025-04-05 22:55","pubTimestamp":1743864920,"startTime":"0","endTime":"0","summary":"Insiders who bought Alumis Inc. ( NASDAQ:ALMS ) stock in the last 12 months were richly rewarded last week. The...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/alumis-reaches-us465m-market-cap-benefiting-insider-stock-bu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2525980730","title":"Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2525980730","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525980730?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:34","pubTimestamp":1743798891,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nTUA8HQXBC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007","BK4139","SLRN"],"gpt_icon":0},{"id":"2522390295","title":"Alumis Inc. Reports 2024 Results and Strategic Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2522390295","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522390295?lang=en_us&edition=fundamental","pubTime":"2025-03-27 12:00","pubTimestamp":1743048049,"startTime":"0","endTime":"0","summary":"Alumis Inc. ( ($ALMS) ) has released its Q4 earnings. Here is a breakdown of the information Alumis Inc. presented to its investors. Alumis Inc. is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alumis-inc-reports-2024-results-and-strategic-merger?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alumis-inc-reports-2024-results-and-strategic-merger?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2522820870","title":"Alumis Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522820870","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522820870?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:54","pubTimestamp":1742986440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 06:54 ET (10:54 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2522885443","title":"Sector Update: Health Care Stocks Decline Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2522885443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522885443?lang=en_us&edition=fundamental","pubTime":"2025-03-26 01:56","pubTimestamp":1742925375,"startTime":"0","endTime":"0","summary":"Health care stocks were falling Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each down about 1.1%.The iShares Biotechnology ETF  fell 1.4%.In corporate news, 23andMe's  customers were asked by New York Attorney General Letitia James to take action for protection of their data as the company goes through bankruptcy, the state prosecutor's office said in a consumer alert Tuesday. 23andMe shares were falling past 13%.Merck  secured exclusive global rights to develop and sell China-based Jiangsu Hengrui Pharmaceuticals' heart disease drug in a deal worth up to about $2 billion. Merck shares were down 4.1%.Alumis  shares rose past 7% after the company and Kaken Pharmaceutical said they signed a collaboration and licensing agreement to develop, manufacture, and commercialize ESK-001 for dermatology indications in Japan, with an option to expand the license to include rheumatological and gastrointestinal diseases.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS","LU0985320562.USD","LU0106261372.USD","LU2023250843.SGD","LU1571399168.USD","SG9999002232.USD","LU1116320901.HKD","LU1061106388.HKD","IE00BSNM7G36.USD","SG9999014542.SGD","LU1989771016.USD","LU1066051498.USD","LU1069347547.HKD","LU1983299246.USD","BK4588","LU0203345920.USD","LU0203347892.USD","LU0122379950.USD","SG9999001176.USD","LU1035773651.USD","LU1093756168.USD","BK4534","MRK","LU0238689110.USD","SG9999014567.USD","LU0211331839.USD","SG9999015358.SGD","XLV","LU2468319806.SGD","IE0002141913.USD","LU2112291526.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0861579265.USD","IE000M9KFDE8.USD","IBB","LU0320765489.SGD","LU1116320737.USD","LU1934455863.HKD","BK4516","LU1941712264.USD","LU1037948541.HKD","ME","LU2089984988.USD","SG9999013999.USD","IE00BN8TJ469.HKD","LU2361044949.HKD","LU1917777945.USD","MEHCQ","SG9999001176.SGD","LU2106854487.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":102,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-19","symbol":"ALMS","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"ALMS","fiscalQuarterEnding":"2024/09","expectedEps":-1.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-1.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1738296000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2025-05-02","current":-0.708214,"percent":0.984772,"low":-5.220865,"twenty":-3.455859,"median":-1.978975,"eighty":-1.148876,"high":-0.660137,"avg":-2.316139,"sd":1.085681,"marketCap":208380062},"quantilePoints":[{"date":"2024-06-28","current":-5.220865,"twenty":-5.220865,"median":-5.220865,"eighty":-5.220865,"marketCap":881360393},{"date":"2024-07-05","current":-3.577828,"twenty":-4.31182,"median":-3.851156,"eighty":-3.577828,"marketCap":603991092},{"date":"2024-07-12","current":-3.798947,"twenty":-4.001025,"median":-3.825051,"eighty":-3.577828,"marketCap":641319297},{"date":"2024-07-15","current":-3.405847,"twenty":-3.980142,"median":-3.798947,"eighty":-3.577828,"marketCap":574958044},{"date":"2024-08-02","current":-4.08515,"twenty":-4.063676,"median":-3.825051,"eighty":-3.577828,"marketCap":689634611},{"date":"2024-08-09","current":-3.930629,"twenty":-4.063676,"median":-3.914533,"eighty":-3.58397,"marketCap":663549141},{"date":"2024-08-16","current":-3.699952,"twenty":-4.025518,"median":-3.855481,"eighty":-3.617622,"marketCap":699416662},{"date":"2024-08-23","current":-3.709695,"twenty":-3.973459,"median":-3.817957,"eighty":-3.659922,"marketCap":701258562},{"date":"2024-08-30","current":-3.67516,"twenty":-3.943506,"median":-3.741353,"eighty":-3.65762,"marketCap":694730166},{"date":"2024-09-06","current":-3.390241,"twenty":-3.930629,"median":-3.739914,"eighty":-3.608539,"marketCap":640870897},{"date":"2024-09-13","current":-3.240587,"twenty":-3.915649,"median":-3.699952,"eighty":-3.511116,"marketCap":612581180},{"date":"2024-09-20","current":-3.272245,"twenty":-3.914533,"median":-3.679477,"eighty":-3.395997,"marketCap":618565543},{"date":"2024-09-27","current":-3.444923,"twenty":-3.859807,"median":-3.655014,"eighty":-3.33556,"marketCap":651207524},{"date":"2024-10-04","current":-2.886598,"twenty":-3.851156,"median":-3.617387,"eighty":-3.295269,"marketCap":545665119},{"date":"2024-10-11","current":-2.961425,"twenty":-3.850149,"median":-3.577828,"eighty":-3.211808,"marketCap":559809977},{"date":"2024-10-18","current":-3.200296,"twenty":-3.817957,"median":-3.47802,"eighty":-3.18015,"marketCap":604964718},{"date":"2024-10-25","current":-3.444923,"twenty":-3.798947,"median":-3.465068,"eighty":-3.200296,"marketCap":651207524},{"date":"2024-10-31","current":-3.231953,"twenty":-3.752872,"median":-3.462191,"eighty":-3.209506,"marketCap":610949081},{"date":"2024-11-08","current":-3.367218,"twenty":-3.741353,"median":-3.447801,"eighty":-3.218715,"marketCap":636518633},{"date":"2024-11-15","current":-2.144174,"twenty":-3.741353,"median":-3.444923,"eighty":-3.209506,"marketCap":511972947},{"date":"2024-11-22","current":-2.15101,"twenty":-3.739051,"median":-3.433411,"eighty":-3.073089,"marketCap":513605166},{"date":"2024-11-29","current":-2.109995,"twenty":-3.736748,"median":-3.419021,"eighty":-3.008623,"marketCap":503811848},{"date":"2024-12-06","current":-1.964163,"twenty":-3.720056,"median":-3.405847,"eighty":-2.970059,"marketCap":468991158},{"date":"2024-12-13","current":-1.989228,"twenty":-3.703849,"median":-3.378729,"eighty":-2.667081,"marketCap":474975964},{"date":"2024-12-20","current":-1.966442,"twenty":-3.691984,"median":-3.312536,"eighty":-2.153744,"marketCap":469535232},{"date":"2024-12-27","current":-1.916313,"twenty":-3.685521,"median":-3.301025,"eighty":-2.142807,"marketCap":457565620},{"date":"2025-01-03","current":-1.873019,"twenty":-3.682067,"median":-3.286635,"eighty":-2.0626,"marketCap":447228227},{"date":"2025-01-10","current":-1.752253,"twenty":-3.67516,"median":-3.266489,"eighty":-2.0029,"marketCap":418392344},{"date":"2025-01-17","current":-1.775039,"twenty":-3.672282,"median":-3.247782,"eighty":-1.966442,"marketCap":423833077},{"date":"2025-01-24","current":-1.497048,"twenty":-3.658468,"median":-3.227637,"eighty":-1.954138,"marketCap":357456138},{"date":"2025-01-31","current":-1.531227,"twenty":-3.654166,"median":-3.211808,"eighty":-1.919959,"marketCap":365617237},{"date":"2025-02-07","current":-1.501605,"twenty":-3.631778,"median":-3.162882,"eighty":-1.882133,"marketCap":358544284},{"date":"2025-02-14","current":-1.162092,"twenty":-3.62163,"median":-3.070787,"eighty":-1.832004,"marketCap":277477367},{"date":"2025-02-21","current":-1.168928,"twenty":-3.613315,"median":-3.018984,"eighty":-1.784609,"marketCap":279109587},{"date":"2025-02-28","current":-1.064112,"twenty":-3.590112,"median":-2.978693,"eighty":-1.743594,"marketCap":254082217},{"date":"2025-03-07","current":-1.162092,"twenty":-3.577828,"median":-2.970059,"eighty":-1.696654,"marketCap":277477367},{"date":"2025-03-14","current":-1.045883,"twenty":-3.561975,"median":-2.844868,"eighty":-1.612801,"marketCap":249729630},{"date":"2025-03-21","current":-0.660137,"twenty":-3.530406,"median":-2.358363,"eighty":-1.527581,"marketCap":194234157},{"date":"2025-03-28","current":-0.869088,"twenty":-3.513232,"median":-2.153288,"eighty":-1.493402,"marketCap":255714436},{"date":"2025-04-04","current":-1.579152,"twenty":-3.504209,"median":-2.144174,"eighty":-1.320049,"marketCap":464638572},{"date":"2025-04-11","current":-1.262952,"twenty":-3.478882,"median":-2.109995,"eighty":-1.320049,"marketCap":371602043},{"date":"2025-04-17","current":-0.937506,"twenty":-3.463917,"median":-2.033661,"eighty":-1.195689,"marketCap":275845147},{"date":"2025-04-25","current":-0.796972,"twenty":-3.46104,"median":-2.0029,"eighty":-1.164826,"marketCap":234495579},{"date":"2025-05-02","current":-0.708214,"twenty":-3.455859,"median":-1.978975,"eighty":-1.148876,"marketCap":208380062}],"updateTime":1746327926862}}}